Correlation Between Edgewise Therapeutics and Viking Therapeutics
Can any of the company-specific risk be diversified away by investing in both Edgewise Therapeutics and Viking Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Edgewise Therapeutics and Viking Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Edgewise Therapeutics and Viking Therapeutics, you can compare the effects of market volatilities on Edgewise Therapeutics and Viking Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Edgewise Therapeutics with a short position of Viking Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Edgewise Therapeutics and Viking Therapeutics.
Diversification Opportunities for Edgewise Therapeutics and Viking Therapeutics
0.22 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Edgewise and Viking is 0.22. Overlapping area represents the amount of risk that can be diversified away by holding Edgewise Therapeutics and Viking Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Viking Therapeutics and Edgewise Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Edgewise Therapeutics are associated (or correlated) with Viking Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Viking Therapeutics has no effect on the direction of Edgewise Therapeutics i.e., Edgewise Therapeutics and Viking Therapeutics go up and down completely randomly.
Pair Corralation between Edgewise Therapeutics and Viking Therapeutics
Given the investment horizon of 90 days Edgewise Therapeutics is expected to generate 1.53 times more return on investment than Viking Therapeutics. However, Edgewise Therapeutics is 1.53 times more volatile than Viking Therapeutics. It trades about 0.15 of its potential returns per unit of risk. Viking Therapeutics is currently generating about -0.01 per unit of risk. If you would invest 1,788 in Edgewise Therapeutics on August 31, 2024 and sell it today you would earn a total of 1,432 from holding Edgewise Therapeutics or generate 80.09% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 98.44% |
Values | Daily Returns |
Edgewise Therapeutics vs. Viking Therapeutics
Performance |
Timeline |
Edgewise Therapeutics |
Viking Therapeutics |
Edgewise Therapeutics and Viking Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Edgewise Therapeutics and Viking Therapeutics
The main advantage of trading using opposite Edgewise Therapeutics and Viking Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Edgewise Therapeutics position performs unexpectedly, Viking Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Viking Therapeutics will offset losses from the drop in Viking Therapeutics' long position.Edgewise Therapeutics vs. Cue Biopharma | Edgewise Therapeutics vs. Eliem Therapeutics | Edgewise Therapeutics vs. Inhibrx | Edgewise Therapeutics vs. Molecular Partners AG |
Viking Therapeutics vs. Cue Biopharma | Viking Therapeutics vs. Eliem Therapeutics | Viking Therapeutics vs. Inhibrx | Viking Therapeutics vs. Molecular Partners AG |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Complementary Tools
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |